RS20060252A - Pelletes containing venlafaxine hydrochloride - Google Patents

Pelletes containing venlafaxine hydrochloride

Info

Publication number
RS20060252A
RS20060252A YUP-2006/0252A YUP20060252A RS20060252A RS 20060252 A RS20060252 A RS 20060252A YU P20060252 A YUP20060252 A YU P20060252A RS 20060252 A RS20060252 A RS 20060252A
Authority
RS
Serbia
Prior art keywords
weight
pellets
venlafaxine hydrochloride
pelletes
chloride
Prior art date
Application number
YUP-2006/0252A
Other languages
English (en)
Inventor
Pal Fekete
Tibor Korbely
Agnes Bozso
Eszter Moricz
Original Assignee
Egis Gyogyszergyar Rt.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Rt., filed Critical Egis Gyogyszergyar Rt.,
Publication of RS20060252A publication Critical patent/RS20060252A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Pronalazak se odnosi na kuglice koje sadrže venlafaksin hlorovodonik i postupak za njihovu proizvodnju. Kuglice, u skladu sa pronalaskom, su gotovo sferične u obliku i sadrže farmaceutski aktivan venlafaksin hlorovodonik u količini od najviše 80% težinski, dalje 10 do 60% težinski natrijum hlorida i/ili kalijum hlorida, 10 do 60% težinski mikrokristalne celuloze i po potrebi druge farmaceutski prihvatljive ekscipijente i/ili aditive koji započinju stvaranje kuglica. Pomenute kuglice su posebno pogodne da budu obavijene sa slojem koji obezbeđuje kontrolisano oslobađanje aktivnog sastojka.
YUP-2006/0252A 2003-10-10 2004-10-08 Pelletes containing venlafaxine hydrochloride RS20060252A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0303382A HUP0303382A2 (hu) 2003-10-10 2003-10-10 Venlafaxin-hidroklorid-tartalmú pelletek
PCT/HU2004/000095 WO2005034930A1 (en) 2003-10-10 2004-10-08 Pellets containing venlafaxine hydrochloride

Publications (1)

Publication Number Publication Date
RS20060252A true RS20060252A (en) 2008-08-07

Family

ID=90001704

Family Applications (2)

Application Number Title Priority Date Filing Date
RS20060252A RS52150B (sr) 2003-10-10 2004-10-08 Pelete koje sadrže venlafaksin hlorovodonik
YUP-2006/0252A RS20060252A (en) 2003-10-10 2004-10-08 Pelletes containing venlafaxine hydrochloride

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RS20060252A RS52150B (sr) 2003-10-10 2004-10-08 Pelete koje sadrže venlafaksin hlorovodonik

Country Status (23)

Country Link
EP (1) EP1677777B1 (sr)
CN (1) CN1882321B (sr)
AT (1) ATE359771T1 (sr)
AU (1) AU2004280132B2 (sr)
BG (1) BG109539A (sr)
CY (1) CY1106693T1 (sr)
CZ (1) CZ2006269A3 (sr)
DE (1) DE602004006009T2 (sr)
DK (1) DK1677777T3 (sr)
EA (1) EA009695B1 (sr)
ES (1) ES2285538T3 (sr)
HK (1) HK1098364A1 (sr)
HR (2) HRP20060136A2 (sr)
HU (1) HUP0303382A2 (sr)
IL (1) IL174830A (sr)
NO (1) NO20062082L (sr)
PL (2) PL1677777T3 (sr)
PT (1) PT1677777E (sr)
RS (2) RS52150B (sr)
SI (1) SI1677777T1 (sr)
SK (1) SK50442006A3 (sr)
UA (1) UA82268C2 (sr)
WO (1) WO2005034930A1 (sr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
RU2230556C2 (ru) 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
AU2002227383B2 (en) 2000-10-30 2004-07-08 Euro-Celtique S.A. Controlled release hydrocodone formulations
IL146462A (en) 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
US20080193524A1 (en) * 2005-07-28 2008-08-14 Dr. Reddy's Laboratories Ltd. Extended Release Venlafaxine Compositions
EA014262B1 (ru) * 2006-05-19 2010-10-29 Эгиш Дьёдьсердьяр Ньильваношан Мюкёдё Ресвеньтаршашаг Способ получения гранулированной массы
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
EP2579857A1 (en) * 2010-05-11 2013-04-17 Cima Labs Inc. Alcohol-resistant extended release dosage forms comprising venlafaxine
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク． メトプロロールを含むアルコール耐性持続放出性経口剤形
EA201590776A1 (ru) * 2012-12-19 2015-11-30 Ратиофарм Гмбх Пеллеты с пленочным покрытием
CN103893151B (zh) * 2012-12-31 2018-04-27 石药集团中奇制药技术（石家庄）有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
WO2015065547A1 (en) 2013-10-31 2015-05-07 Cima Labs Inc. Immediate release abuse-deterrent granulated dosage forms
WO2020225773A1 (en) 2019-05-07 2020-11-12 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine
US20220062200A1 (en) 2019-05-07 2022-03-03 Clexio Biosciences Ltd. Abuse-deterrent dosage forms containing esketamine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
EP1331003B1 (en) * 1996-03-25 2015-08-26 Wyeth LLC Extended release formulation containing venlafaxine
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
CN1334080A (zh) * 2001-07-25 2002-02-06 成都康弘制药有限公司 盐酸万拉法新缓释片及其制备方法
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
AU2003219117A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Extended release venlafaxine formulations

Also Published As

Publication number Publication date
BG109539A (bg) 2006-11-30
EP1677777A1 (en) 2006-07-12
PL379541A1 (pl) 2006-10-02
DK1677777T3 (da) 2007-09-03
HUP0303382D0 (en) 2003-12-29
PT1677777E (pt) 2007-06-21
WO2005034930A1 (en) 2005-04-21
SK50442006A3 (sk) 2006-08-03
EA200600675A1 (ru) 2006-08-25
PL1677777T3 (pl) 2007-08-31
DE602004006009D1 (de) 2007-05-31
ES2285538T3 (es) 2007-11-16
HRP20070322T3 (en) 2007-09-30
AU2004280132A1 (en) 2005-04-21
CN1882321A (zh) 2006-12-20
HUP0303382A2 (hu) 2005-08-29
HRP20060136A2 (en) 2006-06-30
CN1882321B (zh) 2011-06-08
NO20062082L (no) 2006-05-09
CZ2006269A3 (cs) 2006-07-12
IL174830A0 (en) 2008-04-13
IL174830A (en) 2010-04-15
EA009695B1 (ru) 2008-02-28
EP1677777B1 (en) 2007-04-18
HK1098364A1 (en) 2007-07-20
RS52150B (sr) 2012-08-31
AU2004280132B2 (en) 2009-10-22
SI1677777T1 (sl) 2007-10-31
DE602004006009T2 (de) 2008-01-10
UA82268C2 (uk) 2008-03-25
CY1106693T1 (el) 2012-05-23
ATE359771T1 (de) 2007-05-15

Similar Documents

Publication Publication Date Title
HK1098364A1 (en) Pellets containing venlafaxine hydrochloride
MX2010013766A (es) Rasagilina para modificacion de enfermedad de parkinson.
SG153830A1 (en) Galenic formulations of organic compounds
SG158168A1 (en) 5ht2c receptor modulator compositions and methods of use
IL177243A0 (en) Extended release coated minitablets of venlafaxine hydrochloride
RS54050B1 (sr) Formulacije i metode za lečenje amiloidoze
MX2010007672A (es) Composicion estabilizada de liberacion sostenida de clorhidrato de bupropion y proceso para su preparacion.
IS2393B (is) Lyfjablanda sem felur í sér N-((1-N-bútýl-4-píperídínýl)metýl)-3,4-díhýdró-2H-(1,3)oxasínó(3,2-A)indól-10-karboxamíð eða salt og aðferð þar að lútandi sem felur í sér þurrkornamyndun
MX2007014963A (es) Composicion de liberacion modificada de al menos una forma de venlafaxina.
HRP20100373T4 (hr) Upotreba kombinacije morfina s najmanje jednim opijatnim antagonistom u liječenju ovisnosti o opijatima i u sprječavanju neoralne zloupotrebe opijata kod ovisnika opijatima
EA201170784A1 (ru) Гранулы тамсулозина для фиксированной комбинации
PL1589014T3 (pl) Sposób syntezy pochodnych 1,3-dihydro-2H-3-benzazepin-2-onu i jego zastosowanie do wytwarzania iwabradyny i jej dopuszczalnych farmaceutycznie soli
JP2011516544A5 (sr)
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.
TNSN06003A1 (en) Saquinavir mesylate oral dosage form
SG170037A1 (en) Compositions useful for reducing nephrotoxicity and methods of use thereof
WO2007069033A3 (en) Pharmaceutical compositions comprising dexibuprofen, an opiate analgesic and paracetamol
GR1004331B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας αλενδρονικου οξεος
TW200631600A (en) Hair fitness/body improving agent and hair cosmetic
WO2006011001A3 (en) Controlled release compositions of divalproex sodium
MY134311A (en) Medicament with delayed active constituent release containing 1-dimethylamino-3-(3-methoxyphenyl)-2-methylpentan-3-ol
WO2005115092A3 (en) Micronized oral pharmaceutical composition
TNSN06242A1 (en) Extended release coated minitablets of venlafaxine hydrochloride
UA99678C2 (ru) КОМБИНИРОВАННАЯ ДОЗИРОВАННАЯ ФОРМА, СОДЕРЖАЩАЯ ТАМСУЛОЗИН И ИНГИБИТОР ТЕСТОСТЕРОН-5α-РЕДУКТАЗЫ